dc.contributorHospital Veterinario Anhembi-Morumbi
dc.contributorUniversidade de Brasília (UnB)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:21:05Z
dc.date.accessioned2022-10-05T17:52:57Z
dc.date.available2014-05-27T11:21:05Z
dc.date.available2022-10-05T17:52:57Z
dc.date.created2014-05-27T11:21:05Z
dc.date.issued2004-06-01
dc.identifierCanadian Veterinary Journal, v. 45, n. 6, p. 481-485, 2004.
dc.identifier0008-5286
dc.identifierhttp://hdl.handle.net/11449/67758
dc.identifier2-s2.0-3342942761
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3917374
dc.description.abstractThe cardiovascular, respiratory, and anesthetic effects of medetomidine-ketamine (20 μg/kg bodyweight [BW] and 10 mg/kg BW) (MK group) or dexmedetomidine-ketamine (10 μg/kg BW and 10 mg/kg BW) (DK group) were studied in golden-headed lion tamarins. Heart rate decreased after administration of both combinations; this reduction was statistically greater in the DK group than in the MK group after 15 and 45 minutes. Systolic arterial pressure decreased in a similar way in both groups, except at 15 minutes, when systolic arterial pressure was significantly lower in the DK group. Diastolic arterial pressure, mean arterial pressure, respiratory rate, and rectal temperature were progressively reduced in all groups. Sedation time was significantly shorter and anesthesia time was significantly longer in the DK group compared with MK group. Anesthetic quality and analgesia scores were significantly greater at 5 and 15 minutes in the DK group compared with the MK group. The administration of dexmedetomidine-ketamine is as safe and effective as the administration of medetomidine-ketamine in tamarins.
dc.languageeng
dc.relationCanadian Veterinary Journal
dc.relation0.558
dc.relation0,321
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectalpha 2 adrenergic receptor stimulating agent
dc.subjectdexmedetomidine
dc.subjectketamine
dc.subjectmedetomidine
dc.subjectvetaset
dc.subjectxylazine
dc.subjectanalgesia
dc.subjectanalgesic activity
dc.subjectanesthesia
dc.subjectbreathing rate
dc.subjectcardiovascular effect
dc.subjectcontrolled study
dc.subjectdiastolic blood pressure
dc.subjectdose time effect relation
dc.subjectdrug efficacy
dc.subjectdrug potentiation
dc.subjectdrug receptor binding
dc.subjectdrug safety
dc.subjectfemale
dc.subjectheart rate
dc.subjectlion
dc.subjectmale
dc.subjectmean arterial pressure
dc.subjectmuscle relaxation
dc.subjectnonhuman
dc.subjectrectum temperature
dc.subjectrespiratory function
dc.subjectscoring system
dc.subjectsedation
dc.subjectstatistical significance
dc.subjectsystolic blood pressure
dc.subjectveterinary medicine
dc.subjectAnalgesia
dc.subjectAnesthetics, Combined
dc.subjectAnesthetics, Dissociative
dc.subjectAnimals
dc.subjectBlood Pressure
dc.subjectCallitrichinae
dc.subjectDexmedetomidine
dc.subjectFemale
dc.subjectHeart Rate
dc.subjectHypnotics and Sedatives
dc.subjectKetamine
dc.subjectMale
dc.subjectMedetomidine
dc.subjectRandom Allocation
dc.subjectRespiration
dc.subjectSafety
dc.subjectTime Factors
dc.subjectLeontopithecus chrysomelas
dc.subjectPanthera leo
dc.titleComparison of medetomidine-ketamine and dexmedetomidine-ketamine anesthesia in golden-headed lion tamarins
dc.typeArtigo


Este ítem pertenece a la siguiente institución